Preclinical toxicology from a top pre-clinical Contract Research Organization in Eastern Europe.
Our company is an independent CRO based in the United States that offers preclinical drug testing in state-of-the art, GLP-certified testing laboratories in Eastern Europe. Our research facilities are overseen by the UNAMS and Ministry of Health and offer services for commercial development of new drug discoveries as part of their main purpose. The CRO was created to provide the high quality, inexpensive services of these facilities to emerging bio-technology companies in the United States and Europe, thereby offering a smart option for promoting development programs quickly and at much lower cost than other commercial CROs. We provide a broad range of pre-clinical studies including medicine safety, chronic and acute toxicity, pharma screening, bioavailability, bioequivalence, and full in vitro and in vivo screening for anti-cancer activity.
Our pre-clinical Contract Research Organization is able to price pre-clinical services far below other Contract Research Organizations since we maintain a very low overhead in the USA and conduct all testing in Kiev where labor and lab costs are much lower. Our team in the U.S. is comprised of only of the organization principals who deal directly with customers; we don’t have any promotion costs aside from our website, and no main offices, supporting staff or other overhead to inflate costs. We have much lower study conduct prices in Kiev, UA due to much lower labor rates and are happy to provide our best rates for longer and more complex preclinical tests where labor is the most significant part of the overall cost. Since we use the same reliable international providers for lab animals, reagents and lab supplies as other Contract Research Organizations, we don’t have any cost savings on these items and so less overall cost savings for very short-term pre-clinical tests. But, regardless of your test protocol and length, our goal is to give our clients the best possible value for their money.